This article is more than 5 years old. Information may no longer be current.

Nidek gains U.S. approval for perimetry/fundus imaging device

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

GREENSBORO, N.C. — A combination perimetry and fundus imaging device has been granted U.S. regulatory approval, according to Nidek executives. The MP-1 Micro Perimeter will be introduced in the United States for the retina and glaucoma markets.

The MP-1 Micro Perimeter features combined perimetry and fundus imaging; computerized microperimetry; 45-degree non-mydriatic digital fundus photography; high-speed, online image tracking; quantitative assessment of fixation; mapping of scotomas; selectable built-in or custom perimetry programs and fully automated examinations with selected target strategies, said Hideo Ozawa, Nidek’s founder and president.

Mr. Ozawa believes the device could be used in assisting the diagnosis of age-related macular degeneration, choroidal neovascularization, diabetic retinopathy, maculopathies and scotomas, to name a few.